0001562180-22-000439.txt : 20220112
0001562180-22-000439.hdr.sgml : 20220112
20220112211006
ACCESSION NUMBER: 0001562180-22-000439
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220110
FILED AS OF DATE: 20220112
DATE AS OF CHANGE: 20220112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stock Elyse
CENTRAL INDEX KEY: 0001785732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 22527692
BUSINESS ADDRESS:
BUSINESS PHONE: (203) 404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-01-10
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001785732
Stock Elyse
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
false
true
false
false
Chief Medical Officer
Common Shares
2022-01-10
4
M
false
937.00
0.00
A
5374.00
I
By Spouse
Common Shares
11090.00
D
Restricted Share Unit Award
2022-01-10
4
M
false
937.00
0.00
A
Common Shares
937.00
938.00
I
By Spouse
Each restricted share unit represents the contingent right to receive one common share of the Issuer.
The reporting person was granted 3,750 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023, subject to the reporting person's continued service with the Issuer at each vesting date.
Not applicable.
/s/ George Clark, Attorney-in-Fact
2022-01-12